The young founder teaching big pharma a new way to reverse aging
LEVITY - 21-Nov-2025Targeted epigenetic editing could deliver durable, precise therapies for aging-related diseases
Join the club for FREE to access the whole archive and other member benefits.
Targeted epigenetic editing could deliver durable, precise therapies for aging-related diseases
Spermidine shows early signs of improving memory, but clinical results remain inconsistent
Metabolic fingerprints from 500,000 people reveal risks 10–15 years before illness
Lab-grown corneal implant safely integrated and returned sight in initial human use
Natural nozzle enables micro-scale 3D printing at under one dollar each
New Hevolution–Nanobiosym deal accelerates AI-driven metabolic and ageing diagnostics
A widower’s new relationship after cryopreserving his wife ignites a fierce ethical debate in China
New DNA origami nanorobots can store energy and perform multistep tasks without external power
Boosting telomerase with engineered RNA reduced ageing and fibrosis in human lung tissue
Ageing clocks reveal 27% more drug targets, speeding multi-disease therapy
Walking performance in non-diabetic PAD patients remained unchanged despite metformin treatment
A centuries-old Greenland shark reveals how slow life in the deep sea fuels extreme longevity
AbbVie ends its $1.75B Calico deal after the ALS drug fosigotifator failed in phase 2/3 trials
The company hopes to begin human testing in the next few years
Insilico’s AI cut drug discovery to 18 months, spurring Lilly’s investment
Graphene-based BCIs use Azure AI to adapt in real time for Parkinson’s and stroke therapy
Low-dose antibiotics trigger microbes to make metabolites that improve longevity and metabolism
CRISPR therapy cut LDL and triglycerides by roughly 50% after a single infusion
PEG-free stealth shield lets enzyme nanocarriers circulate 100+ hours and starve tumours in mice
Non-invasive ultrasound boosted debris clearance and survival in mice with haemorrhagic stroke
Where scientists, startups, and self-experimenters converge on one question—how far can ageing really be pushed back?
AI was judged more empathic than doctors using written responses, revealing a system-driven empathy gap
Funding accelerates Stentrode’s clinical progress and hands-free device control for paralysis
MOTE records neural activity for over a year and transmits safely through MRI environments
Suleyman argues AI must stay powerful but controllable to deliver safe, society-wide benefits